secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-07-28T20:50:54+00:00
Accession:  0001193125-26-321176
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics adjourns special meeting due to insufficient votes for governance amendment
--------------------------------------------------------------------------------

- Special meeting on July 27, 2026 adjourned; proposal to replace supermajority voting and allow written consent lacked sufficient votes.
- Proposal requires 75% affirmative vote; only 67.7% of shares present, but votes not enough to approve.
- Meeting reconvenes August 17, 2026; previously submitted proxies remain valid unless revoked.
- Company engaged Sodali & Co. to assist with obtaining adequate votes for the proposal.
- Record date remains May 28, 2026; no changes to the proposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526321176/0001193125-26-321176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526321176/d105624d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-321176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer